	PEOPLE	CENTERS	COMMUNITIES	RESEARCH STORIES

DEVELOPMENT OF DRUGS TO TARGET ARGININE BIOSYTHESIS IN MYCOBACTERIUM TUBERCULOSIS

DEVELOPMENT OF DRUGS TO TARGET ARGININE BIOSYTHESIS IN MYCOBACTERIUM TUBERCULOSIS

PI: Sangeeta Tiwari

Sponsor: NIH - NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

Biological Sciences

Amount awarded: $1,510,000

This research enhances novel drugs to shorten tuberculosis chemotherapy.

Posting date: Mon, 04/26/2021

Award start date: Thu, 04/22/2021

Award end date: Mon, 03/31/2025

Some of the content on this web site includes information taken from UTEP's Faculty Success (formerly Digital Measures) and Marketing and Communications.
This material is based upon work supported in part by the Research & Innovation and the National Science Foundation under Grant No. DUE-0963648 and CREST Grant No. HRD-1242122. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation (NSF).